Literature DB >> 24014928

Rutin exerts antiulcer effect by inhibiting the gastric proton pump.

Shagun Dubey1, Aditya Ganeshpurkar, Abhishek Shrivastava, Divya Bansal, Nazneen Dubey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24014928      PMCID: PMC3757621          DOI: 10.4103/0253-7613.115011

Source DB:  PubMed          Journal:  Indian J Pharmacol        ISSN: 0253-7613            Impact factor:   1.200


× No keyword cloud information.
Sir, Peptic ulcers are one of the major health problems observed by people all around the globe. Ulcers occur due to the imbalance in acid secretion and mucosal defense. Excess secretion of acid from the parietal cells is due to the hyperactivity of the gastric proton pump.[1] Recent studies on polyphenolic compounds, including flavonoids and phenolic acids, have shown diverse functions, including antioxidant, antiulcer, antihyperglycemic, and antihypertensive properties.[2] Flavonoids are one of the important groups of polyphenolic substances that are abundantly distributed in the plant kingdom and have shown their potential to act in the gastrointestinal tract as antiulcer, antispasmodic, antisecretory or antidiarrheal agents.[3] Flavonoids in different studies have been seen to inhibit the enzyme activity of histidine decarboxylase, and thus, decrease the formation of histamine in the gastric mucosa.[4] They have also shown cytoprotective effects by stimulating the mucosal content of prostaglandins and mucus in the gastric mucosa. A number of them prevent and protect the gastric mucosa against various ulcers produced in experimental models. Rutin (Vitamin P), one of the widely occurring flavonoids, is known for a plethora of pharmacological effects. Studies have shown that rutin scavenges free radicals, suppresses cellular immunity, has an anti-inflammatory effect, as well as anti-carcinogenic and antimicrobial[5678] potential. Rutin has also demonstrated an antiulcer effect, yet its effect on the gastric proton pump is still unknown.[9] Based on the above observations, the aim of the present study was to determine the activity of rutin on the gastric enzyme H+-K+ATPase. Tris-HCL was purchased from Sigma, Germany. Magnesium chloride (MgCl2), Potassium chloride (KCl), methanol, and adenosine triphosphate (ATP) were purchased from Loba Chemie, India. Rutin was purchased from the Central Drug House, India Proton potassium ATPase was prepared from the mucosal scraping of goats, by the method reported by Cheon et al., with the necessary modifications. The stomach from a freshly slaughtered goat was washed gently with tap water. The mucosal layer of the fundus was scrapped and homogenized in an ice cold phosphate buffer, pH 7.4. The homogenate was centrifuged for 20 minutes at 18,000 rpm. The supernatant so obtained was recentrifuged for 60 minutes at 100,000 rpm. The pellet was re-suspended in the homogenization buffer. Different concentrations of the extract, 10 to 50 μg / ml, were incubated in the reaction mixture (40 mM Tris-HCl buffer, pH 7.4, containing 2 mM MgCl2 and 10 μg membrane protein) to make a volume of 1 ml. Next, 2 mM ATP Tris salt was utilized to start the reaction. This preparation was incubated for 20 minutes at 37°C. The reaction was terminated by adding 1 ml of ice-cold trichloroacetic acid (10% v / v). The H+-K+ ATPase activity was assayed in the presence and the absence of different doses of the extract and omeprazole. The amount of inorganic phosphate released from ATP was determined spectrophotometrically at 400 nm.[910] The results were expressed as mean ± standard error of the mean. The experiments were always performed in triplicate. Statistical comparison was performed using the analysis of variance (ANOVA) followed by the Bonferroni's test (*p < 0.05). Rutin showed significant (*p < 0.05) proton pump inhibitory activity in the goat gastric mucosal homogenate [Figure 1]. The inhibitory activity was concentration-dependent, and the results were comparable with the standard drug omeprazole. Rutin reduced the hydrolysis of ATP by the goat gastric ATPase, with IC50 of 36 μg / mL. Omeprazole (10 – 50μg / mL) used as a positive control reduced H+-K+ ATPase activity with an IC50 of 22 μg / mL.
Figure 1

Rutin exerts antiulcer effect by inhibiting the gastric proton pump H+-K+ ATPase activity was measured with 10 – 50 μg / ml of extract and omeprazole. The experiments were always performed in triplicate. The results were expressed as the mean ± standard error of the mean. Statistical comparison was performed using the analysis of variance (ANOVA) followed by Bonferroni's test (*p < 0.05)

Rutin exerts antiulcer effect by inhibiting the gastric proton pump H+-K+ ATPase activity was measured with 10 – 50 μg / ml of extract and omeprazole. The experiments were always performed in triplicate. The results were expressed as the mean ± standard error of the mean. Statistical comparison was performed using the analysis of variance (ANOVA) followed by Bonferroni's test (*p < 0.05) Various phytochemicals such as tannins, flavonoids and triterpenes from plants have earlier shown their potential to treat ulcers. Catechin and epicatechin have previously been proven as non-competitive inhibitors of H+-K+-ATPase. Gastric ulcers have been previously treated using plant polyphenols and flavonoids. It has been earlier shown in various studies that gastric damage can be defended by flavonoids. Flavonoids have proven to be excellent antioxidants; some of which are competent in enhancing prostaglandin in the mucosal content. Besides this, they safeguard the capillary integrity and reinstate the normal function of the mucus membrane. H+-K+ ATPase is a key enzyme in inducing acidity; thus in this study, the ability of rutin to inhibit H+-K+ ATPase in vitro is studied.[3579] It is clear from the results that rutin exerts an antiulcer potential by virtue of the inhibition of the proton pump. It shows a concentrated graded response on H+-K+ ATPase against the standard drug omeprazole. It can be concluded that rutin inhibits H+-K+ ATPase, a key enzyme responsible for the secretion of acid, and thus shows antiulcer activity.
  10 in total

1.  Comparative study of flavonoids in experimental models of inflammation.

Authors:  Alejandra Ester Rotelli; Teresita Guardia; Américo Osvaldo Juárez; Nadir Ernesto de la Rocha; Lilian Eugenia Pelzer
Journal:  Pharmacol Res       Date:  2003-12       Impact factor: 7.658

2.  Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia.

Authors:  E E Deschner; J Ruperto; G Wong; H L Newmark
Journal:  Carcinogenesis       Date:  1991-07       Impact factor: 4.944

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  The activity of compounds extracted from feverfew on histamine release from rat mast cells.

Authors:  N A Hayes; J C Foreman
Journal:  J Pharm Pharmacol       Date:  1987-06       Impact factor: 3.765

Review 5.  Gastric cytoprotection.

Authors:  S J Konturek
Journal:  Scand J Gastroenterol       Date:  1985-06       Impact factor: 2.423

Review 6.  Free radical scavenging and antioxidant activity of plant flavonoids.

Authors:  C Kandaswami; E Middleton
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

Review 7.  Flavonoids: old and new aspects of a class of natural therapeutic drugs.

Authors:  G Di Carlo; N Mascolo; A A Izzo; F Capasso
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 8.  The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer.

Authors:  E Middleton; C Kandaswami; T C Theoharides
Journal:  Pharmacol Rev       Date:  2000-12       Impact factor: 25.468

9.  Endothelium-dependent vasorelaxation effect of rutin-free tartary buckwheat extract in isolated rat thoracic aorta.

Authors:  Yusuke Ushida; Toshiro Matsui; Mitsuru Tanaka; Kiyoshi Matsumoto; Hirokazu Hosoyama; Atsuhiro Mitomi; Yuko Sagesaka; Takami Kakuda
Journal:  J Nutr Biochem       Date:  2008-03-06       Impact factor: 6.048

10.  In vitro H(+) -K(+) ATPase inhibitory potential of methanolic extract of Cissus quadrangularis Linn.

Authors:  Priyanka Yadav; Aditya Ganeshpurkar; Gopal Rai
Journal:  Pharmacognosy Res       Date:  2012-04
  10 in total
  6 in total

1.  Rutin attenuates intestinal toxicity induced by Methotrexate linked with anti-oxidative and anti-inflammatory effects.

Authors:  Raju Gautam; Manjari Singh; Swetlana Gautam; Jitendra Kumar Rawat; Shubhini A Saraf; Gaurav Kaithwas
Journal:  BMC Complement Altern Med       Date:  2016-03-10       Impact factor: 3.659

Review 2.  The Pharmacological Potential of Rutin.

Authors:  Aditya Ganeshpurkar; Ajay K Saluja
Journal:  Saudi Pharm J       Date:  2016-04-30       Impact factor: 4.330

Review 3.  A Review of the Role of Flavonoids in Peptic Ulcer (2010-2020).

Authors:  Catarina Serafim; Maria Elaine Araruna; Edvaldo Alves Júnior; Margareth Diniz; Clélia Hiruma-Lima; Leônia Batista
Journal:  Molecules       Date:  2020-11-20       Impact factor: 4.411

4.  Exploring the inhibitory potential of Saussurea costus and Saussurea involucrata phytoconstituents against the Spike glycoprotein receptor binding domain of SARS-CoV-2 Delta (B.1.617.2) variant and the main protease (Mpro) as therapeutic candidates, using Molecular docking, DFT, and ADME/Tox studies.

Authors:  Selma Houchi; Zakia Messasma
Journal:  J Mol Struct       Date:  2022-04-09       Impact factor: 3.841

5.  Rutin alleviates cardiomyocyte injury induced by high glucose through inhibiting apoptosis and endoplasmic reticulum stress.

Authors:  Jing Wang; Ru Wang; Jiali Li; Zhuhua Yao
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

6.  Evaluation of traditional medicinal plant, Cissus setosa Roxb. (Vitaceae) for antiulcer property.

Authors:  Chinnamaruthu Jayachitra; Senguttuvan Jamuna; Mohammad Ajmal Ali; Subramaniam Paulsamy; Fahad M A Al-Hemaid
Journal:  Saudi J Biol Sci       Date:  2017-03-14       Impact factor: 4.219

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.